Vanguard Group’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-767,154
| Closed | -$859K | – | 4386 |
|
|
2025
Q2 | $859K | Sell |
767,154
-108,415
| -12% | -$132K | ﹤0.01% | 3779 |
|
|
2025
Q1 | $1.01M | Sell |
875,569
-20,781
| -2% | -$38.6K | ﹤0.01% | 3708 |
|
|
2024
Q4 | $5.48M | Buy |
896,350
+6,150
| +0.7% | +$73.1K | ﹤0.01% | 3232 |
|
|
2024
Q3 | $14.7M | Buy |
890,200
+11,579
| +1% | +$127K | ﹤0.01% | 2756 |
|
|
2024
Q2 | $6.04M | Buy |
878,621
+24,963
| +3% | +$214K | ﹤0.01% | 3173 |
|
|
2024
Q1 | $8.24M | Sell |
853,658
-43,491
| -5% | -$504K | ﹤0.01% | 3066 |
|
|
2023
Q4 | $7.46M | Sell |
897,149
-2,858
| -0.3% | -$16.6K | ﹤0.01% | 3115 |
|
|
2023
Q3 | $7.52M | Buy |
900,007
+202,719
| +29% | +$1.72M | ﹤0.01% | 3059 |
|
|
2023
Q2 | $6.44M | Buy |
697,288
+116,926
| +20% | +$1.31M | ﹤0.01% | 3184 |
|
|
2023
Q1 | $7.97M | Buy |
580,362
+3,195
| +0.6% | +$66.1K | ﹤0.01% | 3066 |
|
|
2022
Q4 | $9.82M | Buy |
577,167
+57,190
| +11% | +$1.14M | ﹤0.01% | 2956 |
|
|
2022
Q3 | $11.8M | Buy |
519,977
+9,044
| +2% | +$183K | ﹤0.01% | 2870 |
|
|
2022
Q2 | $9.21M | Sell |
510,933
-319,144
| -38% | -$5.69M | ﹤0.01% | 3041 |
|
|
2022
Q1 | $22.2M | Buy |
830,077
+415,028
| +100% | +$7.73M | ﹤0.01% | 2707 |
|
|
2021
Q4 | $12.2M | Buy |
415,049
+2,490
| +0.6% | +$124K | ﹤0.01% | 3114 |
|
|
2021
Q3 | $27.1M | Buy |
412,559
+2,756
| +0.7% | +$211K | ﹤0.01% | 2680 |
|
|
2021
Q2 | $34.1M | Buy |
409,803
+5,702
| +1% | +$422K | ﹤0.01% | 2570 |
|
|
2021
Q1 | $31M | Sell |
404,101
-36,830
| -8% | -$3.35M | ﹤0.01% | 2572 |
|
|
2020
Q4 | $38.9M | Buy |
440,931
+69,077
| +19% | +$4.86M | ﹤0.01% | 2326 |
|
|
2020
Q3 | $27.4M | Sell |
371,854
-100,018
| -21% | -$5.92M | ﹤0.01% | 2305 |
|
|
2020
Q2 | $34.4M | Sell |
471,872
-28,007
| -6% | -$1.7M | ﹤0.01% | 2185 |
|
|
2020
Q1 | $28.1M | Sell |
499,879
-4,802
| -1% | -$210K | ﹤0.01% | 2133 |
|
|
2019
Q4 | $19.3M | Buy |
504,681
+479,681
| +1,919% | +$12.1M | ﹤0.01% | 2551 |
|
|
2019
Q3 | $443K | Buy |
+25,000
| New | +$505K | ﹤0.01% | 3840 |
|
Other funds holding IGMS
Vanguard Group's IGMS Position: Q3 2025 in Review
Vanguard Group sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 767,154 shares — an estimated $859K sold.
Vanguard Group first reported a position in IGMS in Q3 2019 and held it in 24 quarters. The position peaked at $38.9M in Q4 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Vanguard Group reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Vanguard Group sold 767,154 IGM Biosciences shares in Q3 2025, an estimated $859K.
- Vanguard Group first reported a position in IGM Biosciences in Q3 2019 and held it in 24 quarters.
- Vanguard Group's IGM Biosciences position peaked at $38.9M in Q4 2020.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.